Environmental contamination with steroids
A team of researchers led by Nawed Deshmukh of the School of Pharmacy and Chemistry at Kingston University (London, UK) has published new research using liquid chromatography?tandem mass spectrometry (LC?MS?MS) to identify steroid contamination in environmental water samples in Budapest, Hungary.
A team of researchers led by Nawed Deshmukh of the School of Pharmacy and Chemistry at Kingston University (London, UK) has published new research using liquid chromatography–tandem mass spectrometry (LC–MS–MS) to identify steroid contamination in environmental water samples in Budapest, Hungary.
The synthetic anabolic steroid stanozolol is often misused as a performance-enhancing drug and as an illegal growth aid in veterinary practice. These researchers previously reported stanozolol in hair samples collected from subjects living in Budapest. That finding prompted the current study of environmental contamination with the steroid.
In the study, the team used liquid–liquid extraction using pentane, which they found to be an efficient method for the extraction of stanozolol from water samples. This step was followed by direct detection using LC–MS–MS. The method was capable of detecting a 0.25 pg/mL concentration of stanozolol when only 5 mL of water was processed in the presence of stanozolol-d3 as internal standard. The method developed was found to be efficient, rapid, reproducible, sensitive and robust for the detection of stanozolol in aqueous matrices.
Three out of six samples from the Danube river, collected from December 2009 to November 2010, were found to contain stanozolol at concentrations up to 1.82 pg/mL. In contrast, only one sample (out of six) of urban tap water from the city of Budapest was found to contain stanozolol, at a concentration of 1.19 pg/mL. A total of 15 bottled waters analysed were found to be negative for the steroid.
The study was published in Chemistry Central Journal on 14 October 2011.
This story originally appeared in The Column. Click here to view that issue.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
